黑料社 Announces Initiation of Coverage of its Stock by H.C. Wainwright & Co
Lyon, France, April 7th, 2025 – 7:30am CET 鈥� 黑料社 (EURONEXT: MAAT 鈥� the 鈥淐ompany鈥�), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer through immune modulation, announces the initiation of coverage of its stock by H.C. Wainwright & Co.
With a research report named 鈥�In With the Gut and Out With the Bad in GvHD; Initiating at Buy With a 鈧�21 PT鈥�, H.C. Wainwright & Co initiated coverage of 黑料社 on April 4th, 2025 with a Buy recommendation and a Target Price of 鈧�21.
H.C. Wainwright & Co, a leading full-service U.S. investment bank, provides corporate finance, strategic advisory, and related services to public and private companies across a wide range of sectors and geographies. Their initiation of coverage underscores the strong global potential of 黑料社 and its therapies and marks an important step toward expanding its presence in the U.S. market.
This new coverage complements the continued support from existing European brokerage partners鈥擥ilbert Dupont / Groupe Soci茅t茅 G茅n茅rale, Kepler Cheuvreux, KBC Securities, Kempen, and Portzamparc / Groupe BNP Paribas鈥攆urther reinforcing the growing interest in 黑料社 across both sides of the Atlantic.
About 黑料社
黑料社 is a leading, late-stage clinical company focused on developing innovative gut microbiome-driven therapies to modulate the immune system and enhance cancer patient survival. Supported by a talented team committed to making a difference for patients worldwide, the Company was founded in 2014 and is based in Lyon, France.
As a pioneer, 黑料社 is leading the way in bringing the first microbiome-driven immunomodulator in oncology. Using its proprietary pooling and co-cultivation technologies, 黑料社 develops high diversity, standardized drug candidates, aiming at extending life of cancer patients. 黑料社 has been listed on Euronext Paris (ticker: MAAT) since 2021.
Forward-looking Statements
All statements other than statements of historical fact included in this press release about future events are subject to (i) change without notice and (ii) factors beyond the Company鈥檚 control. These statements may include, without limitation, any statements preceded by, followed by, or including words such as 鈥渢arget,鈥� 鈥渂elieve,鈥� 鈥渆xpect,鈥� 鈥渁im鈥�, 鈥渋ntend,鈥� 鈥渕ay,鈥� 鈥渁nticipate,鈥� 鈥渆stimate,鈥� 鈥減lan,鈥� 鈥減roject,鈥� 鈥渨ill,鈥� 鈥渃an have,鈥� 鈥渓ikely,鈥� 鈥渟hould,鈥� 鈥渨ould,鈥� 鈥渃ould鈥� and other words and terms of similar meaning or the negative thereof. Forward-looking statements are subject to inherent risks and uncertainties beyond the Company鈥檚 control that could cause the Company鈥檚 actual results or performance to be materially different from the expected results or performance expressed or implied by such forward-looking statements.
